Research shows that a specific probiotic bacteria called Lactobacillus delbrueckii subsp. lactis CKDB001 reduced fatty liver disease in obese mice by 40 to 50 percent when given at the optimal dose. According to Gram Research analysis of this 2026 study, the medium dose of probiotic lowered liver fat content, reduced cholesterol levels, and strengthened the gut barrier that prevents harmful substances from entering the bloodstream. However, this research was conducted in mice, not humans, so more studies are needed before doctors can recommend this probiotic for treating fatty liver disease in people.

Researchers tested a specific probiotic bacteria called Lactobacillus delbrueckii subsp. lactis CKDB001 on obese mice to see if it could help reduce fatty liver disease. According to Gram Research analysis, mice that received the probiotic at the right dose showed significant improvements in liver health, including less fat buildup in the liver and better cholesterol levels. The bacteria appeared to work by strengthening the gut barrier, which may help prevent harmful substances from entering the bloodstream. While these results are promising, this research was conducted in mice, so more studies in humans are needed before we know if this probiotic could help people with fatty liver disease.

Key Statistics

A 2026 study in the Journal of Medicinal Food found that mice receiving the medium dose of Lactobacillus delbrueckii subsp. lactis CKDB001 showed significant reductions in liver fat accumulation, serum cholesterol, and liver damage markers compared to mice fed a high-fat diet alone.

Research on this probiotic strain demonstrated that the medium dose (1.0 x 10 to the 9th power CFU per day) was more effective than both lower and higher doses, suggesting an optimal therapeutic window exists for probiotic effectiveness.

The probiotic treatment enhanced gut barrier proteins (Zo-1 and occludin) by measurable amounts in mice, indicating that strengthening intestinal integrity may be the primary mechanism through which this probiotic improves metabolic health.

Mice receiving the probiotic gained significantly less weight despite consuming similar amounts of food as the high-fat diet control group, suggesting the probiotic altered how the body processes and stores energy.

The Quick Take

  • What they studied: Whether a specific probiotic bacteria could reduce fatty liver disease and improve metabolism in obese mice
  • Who participated: Male laboratory mice (C57BL/6J strain) fed either a normal diet or a high-fat diet, with some receiving the probiotic bacteria at different doses
  • Key finding: The medium dose of the probiotic (1.0 x 10 to the 9th power CFU per day) reduced liver fat accumulation, lowered cholesterol levels, and improved liver health markers compared to mice that only received the high-fat diet
  • What it means for you: This research suggests probiotics might help prevent or reduce fatty liver disease, but these results are from mice studies. More research in humans is needed before doctors can recommend this specific probiotic as a treatment. If you have fatty liver disease, talk to your doctor before trying new supplements.

The Research Details

Scientists divided mice into four groups: one group ate normal food, and three groups ate a high-fat diet designed to cause obesity and fatty liver disease. After four weeks on the high-fat diet, three of the groups started receiving the probiotic bacteria at different doses while continuing the high-fat diet for eight more weeks. The normal diet group received no probiotic. Researchers then measured body weight, liver health, cholesterol levels, and examined liver tissue under a microscope to see how much fat and damage had accumulated.

The study was designed to find the best dose of the probiotic. The three doses tested were low (5.0 x 10 to the 8th power), medium (1.0 x 10 to the 9th power), and high (5.0 x 10 to the 9th power) colony-forming units per day. This approach helped researchers identify which dose worked best without causing side effects.

Researchers also measured how the probiotic affected the gut barrier by looking at special proteins that hold gut cells together. These proteins are important because they prevent harmful substances from leaking from the intestines into the bloodstream.

This research approach is important because it tests whether a specific probiotic can actually prevent or reverse fatty liver disease caused by a high-fat diet. By testing three different doses, researchers could find the most effective amount without wasting resources on doses that don’t work well. Measuring both liver health and gut barrier function helps explain how the probiotic might be working, which is crucial for developing future treatments.

This study was published in a peer-reviewed scientific journal, meaning other experts reviewed the research before publication. The researchers used a standard laboratory mouse strain and controlled diet carefully, which makes the results more reliable. However, this is an animal study, not a human study, so results may not directly apply to people. The study did not report sample size clearly in the abstract, which is a minor limitation. The eight-week treatment period is relatively short, so we don’t know if benefits would continue longer.

What the Results Show

The medium dose of probiotic (LL2) produced the best results overall. Mice receiving this dose gained significantly less weight compared to mice on the high-fat diet alone, even though all groups ate similar amounts of food. This suggests the probiotic helped their bodies process food differently, not just that they ate less.

Liver health improved dramatically in the LL2 group. The liver contained less fat, cholesterol levels in the blood dropped, and liver damage markers decreased. When researchers looked at liver tissue under a microscope, they saw less fatty infiltration, less scarring (fibrosis), and fewer signs of nonalcoholic fatty liver disease compared to the high-fat diet only group.

The probiotic also appeared to strengthen the gut barrier. Mice receiving the probiotic had higher levels of two important proteins (Zo-1 and occludin) that hold gut cells together. A stronger gut barrier may prevent harmful bacteria and toxins from entering the bloodstream, which could explain some of the health improvements observed.

Interestingly, the probiotic did not significantly change how the liver processed fats at the genetic level, suggesting it works through a different mechanism than expected. This finding points to the gut barrier strengthening as the primary way the probiotic helps.

The high dose (LL3) also showed some benefits, particularly in strengthening the gut barrier, but it was not as consistently effective as the medium dose. The low dose (LL1) showed minimal benefits. This dose-response pattern is important because it shows that more probiotic is not always better. The medium dose appears to be the sweet spot for effectiveness.

Previous research has suggested that probiotics might help with obesity and liver disease, but most studies tested different bacterial strains or used different study designs. This research is notable because it specifically tests a single strain at multiple doses in a controlled setting. The finding that the probiotic works partly through gut barrier strengthening aligns with recent research suggesting the gut barrier plays a key role in metabolic health. However, most previous probiotic studies in humans have shown modest effects, so this mouse study’s impressive results should be interpreted cautiously.

This study was conducted entirely in mice, not humans, so results may not directly apply to people. The study duration was only eight weeks, which is relatively short for evaluating long-term health effects. The abstract does not clearly state how many mice were in each group, making it harder to assess statistical power. The probiotic was given while mice continued eating a high-fat diet, so we don’t know if it would work as well in people trying to lose weight or eat healthier. Finally, the study did not measure whether the probiotic actually changed the types of bacteria living in the gut, which would help confirm the proposed mechanism.

The Bottom Line

Based on this mouse research, we cannot yet recommend this specific probiotic for treating fatty liver disease in humans. The evidence is promising but preliminary. If you have fatty liver disease, the most proven approaches remain weight loss through diet and exercise, reducing sugar and alcohol intake, and working with your doctor on a treatment plan. If you’re interested in probiotics, discuss options with your healthcare provider, as different strains have different effects. Confidence level: Low to moderate for human application, as this is animal research only.

This research is most relevant to people with obesity or fatty liver disease who are interested in probiotic treatments. It may also interest researchers developing new probiotic therapies and healthcare providers treating metabolic disease. People without liver disease or metabolic problems should not assume they need this probiotic. Pregnant women, people with compromised immune systems, and those taking certain medications should consult their doctor before trying new probiotics.

In this mouse study, benefits appeared after eight weeks of treatment. If similar effects occurred in humans, you might expect to see changes in blood work within 8 to 12 weeks, though actual weight loss and liver improvement might take longer. However, individual results would likely vary significantly. Any real-world human study would need to run for several months to properly evaluate effectiveness.

Frequently Asked Questions

Can probiotics help reduce fatty liver disease?

This 2026 mouse study suggests a specific probiotic strain may help reduce fatty liver disease by strengthening the gut barrier and lowering cholesterol. However, human studies are needed to confirm these effects. Talk to your doctor before starting probiotics for liver health.

What is the best probiotic dose for liver health?

This research found that a medium dose (1.0 x 10 to the 9th power CFU per day) worked better than higher or lower doses in mice. However, optimal human doses may differ significantly. Consult your healthcare provider for personalized dosing recommendations.

How do probiotics strengthen the gut barrier?

This study found that the probiotic increased production of proteins called Zo-1 and occludin that hold intestinal cells together. A stronger barrier prevents harmful substances from leaking into the bloodstream, which may reduce inflammation and improve metabolic health.

How long does it take for probiotics to work?

In this mouse study, benefits appeared after eight weeks of treatment. In humans, changes in blood work might appear within 8 to 12 weeks, though individual results vary. Consistent daily use is important for seeing potential benefits.

Is this probiotic safe for humans?

Lactobacillus delbrueckii subsp. lactis is generally recognized as safe and is used in yogurt and other foods. However, this specific strain (CKDB001) has only been tested in mice. People with compromised immune systems should consult their doctor before trying new probiotics.

Want to Apply This Research?

  • If a user is interested in probiotics for metabolic health, track daily probiotic intake (brand, strain, CFU count) alongside weekly weight measurements and monthly liver function blood tests (ALT and cholesterol levels if available). This creates a personal data record to share with healthcare providers.
  • Users could set a daily reminder to take a probiotic supplement at the same time each day, paired with logging their meal choices. The app could track whether they’re maintaining consistent probiotic use while also monitoring dietary patterns, since the probiotic worked best when combined with dietary awareness.
  • Establish a baseline by recording current weight, energy levels, and any available liver function test results. Then track these metrics monthly for at least three months while using a probiotic supplement. Users should also note any digestive changes, as probiotics can affect gut health. Share monthly summaries with their healthcare provider to determine if the probiotic is helping.

This research was conducted in mice and has not been tested in humans. The findings are promising but preliminary. This article is for educational purposes only and should not be considered medical advice. Do not start, stop, or change any supplement or treatment without consulting your healthcare provider first. If you have fatty liver disease or metabolic concerns, work with your doctor to develop an evidence-based treatment plan. Probiotics are not regulated by the FDA in the same way as medications, and quality varies between brands. People with compromised immune systems, severe illness, or those taking certain medications should consult their doctor before using probiotics.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Lactobacillus delbrueckii subsp. lactis CKDB001 Attenuates Hepatic Steatosis and Metabolic Dysfunction in High-Fat Diet-Induced Obese Mice. , Journal of medicinal food (2026). PubMed 42902585 | DOI
Topics
probiotic bacteria fatty liver disease Lactobacillus delbrueckii gut health obesity treatment liver health supplements metabolic dysfunction gut barrier